Global GLP-1 Therapy Market Research Report 2026(Status and Outlook)
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on GLP-1 Therapy competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.GLP-1 therapy refers to using medicines that activate the glucagon-like peptide-1 receptor to treat type 2 diabetes and/or chronic weight management (obesity/overweight with comorbidities). In 2024, global GLP-1 Therapy production reached approximately 163760 K Unit, with an average global market price of around US$ 325 per unit.Market outlook: GLP-1 therapies are set for sustained hypergrowth over the next 5–10 years as obesity care globalizes beyond type 2 diabetes, supported by compelling outcomes data, expanding payor coverage, and strong consumer pull for chronic weight management.Industry chain (upstream?midstream): Upstream consists of peptide APIs (solid-phase synthesis, high-capacity preparative chromatography, PEGylation/lipidation linkers), device components (autoinjectors, pens, safety needles), and excipients, while midstream innovators integrate long-acting analog design, fill-finish, device pairing, and global regulatory/CMC to deliver branded combination drug–device products.Downstream & ecosystem: Downstream demand flows through endocrinology and primary-care channels, obesity clinics, digital telehealth platforms, and employer/payer programs, with adherence, supply continuity, and step-therapy rules shaping real-world volumes and with compounding and biosimilar entry emerging as price/modality pressure over time.Growth drivers & constraints: Growth is propelled by superior cardiometabolic outcomes (A1c, weight loss, CV risk signals), label and geography expansion, and pipeline next-gen incretin combos (GLP-1/GIP/GCGR), while constraints include manufacturing scale for complex peptides, device capacity, reimbursement variability, GI tolerability/attrition, and eventual price erosion from competition and biosimilars.Economics (gross margins): At scale, branded GLP-1 drug–device products typically achieve ~75–90% gross margins for originators (high list prices, efficient peptide and device supply), ~20–35% for contract manufacturers/device suppliers, and ~10–20% for distribution/dispensing, with blended margins compressing over time as pricing pressure, rebates, and competitive entrants increase.
The global GLP-1 Therapy market size was estimated at USD 53222.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 18.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global GLP-1 Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global GLP-1 Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the GLP-1 Therapy market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the GLP-1 Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of GLP-1 Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global GLP-1 Therapy market size was estimated at USD 53222.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 18.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global GLP-1 Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global GLP-1 Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the GLP-1 Therapy market.
Global GLP-1 Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Novo Nordisk
- Eli Lilly
- Sanofi
- AstraZeneca (historical)
- Teva
- Zealand Pharma
- Pfizer
- Merck (MSD)
Market Segmentation (by Type)
- Injection
- Oral
Market Segmentation (by Application)
- Type 2 Diabetes
- Obesity/Weight Management
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the GLP-1 Therapy Market
Overview of the regional outlook of the GLP-1 Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the GLP-1 Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of GLP-1 Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of GLP-1 Therapy
1.2 Key Market Segments
1.2.1 GLP-1 Therapy Segment by Type
1.2.2 GLP-1 Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLP-1 THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global GLP-1 Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global GLP-1 Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLP-1 THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global GLP-1 Therapy Product Life Cycle
3.3 Global GLP-1 Therapy Sales by Manufacturers (2020-2025)
3.4 Global GLP-1 Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 GLP-1 Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global GLP-1 Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 GLP-1 Therapy Market Competitive Situation and Trends
3.8.1 GLP-1 Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest GLP-1 Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GLP-1 THERAPY INDUSTRY CHAIN ANALYSIS
4.1 GLP-1 Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GLP-1 THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global GLP-1 Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to GLP-1 Therapy Market
5.7 ESG Ratings of Leading Companies
6 GLP-1 THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global GLP-1 Therapy Sales Market Share by Type (2020-2025)
6.3 Global GLP-1 Therapy Market Size by Type (2020-2025)
6.4 Global GLP-1 Therapy Price by Type (2020-2025)
7 GLP-1 THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global GLP-1 Therapy Market Sales by Application (2020-2025)
7.3 Global GLP-1 Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global GLP-1 Therapy Sales Growth Rate by Application (2020-2025)
8 GLP-1 THERAPY MARKET SALES BY REGION
8.1 Global GLP-1 Therapy Sales by Region
8.1.1 Global GLP-1 Therapy Sales by Region
8.1.2 Global GLP-1 Therapy Sales Market Share by Region
8.2 Global GLP-1 Therapy Market Size by Region
8.2.1 Global GLP-1 Therapy Market Size by Region
8.2.2 Global GLP-1 Therapy Market Size by Region
8.3 North America
8.3.1 North America GLP-1 Therapy Sales by Country
8.3.2 North America GLP-1 Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe GLP-1 Therapy Sales by Country
8.4.2 Europe GLP-1 Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific GLP-1 Therapy Sales by Region
8.5.2 Asia Pacific GLP-1 Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America GLP-1 Therapy Sales by Country
8.6.2 South America GLP-1 Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa GLP-1 Therapy Sales by Region
8.7.2 Middle East and Africa GLP-1 Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GLP-1 THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of GLP-1 Therapy by Region(2020-2025)
9.2 Global GLP-1 Therapy Revenue Market Share by Region (2020-2025)
9.3 Global GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America GLP-1 Therapy Production
9.4.1 North America GLP-1 Therapy Production Growth Rate (2020-2025)
9.4.2 North America GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe GLP-1 Therapy Production
9.5.1 Europe GLP-1 Therapy Production Growth Rate (2020-2025)
9.5.2 Europe GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan GLP-1 Therapy Production (2020-2025)
9.6.1 Japan GLP-1 Therapy Production Growth Rate (2020-2025)
9.6.2 Japan GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China GLP-1 Therapy Production (2020-2025)
9.7.1 China GLP-1 Therapy Production Growth Rate (2020-2025)
9.7.2 China GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novo Nordisk
10.1.1 Novo Nordisk Basic Information
10.1.2 Novo Nordisk GLP-1 Therapy Product Overview
10.1.3 Novo Nordisk GLP-1 Therapy Product Market Performance
10.1.4 Novo Nordisk Business Overview
10.1.5 Novo Nordisk SWOT Analysis
10.1.6 Novo Nordisk Recent Developments
10.2 Eli Lilly
10.2.1 Eli Lilly Basic Information
10.2.2 Eli Lilly GLP-1 Therapy Product Overview
10.2.3 Eli Lilly GLP-1 Therapy Product Market Performance
10.2.4 Eli Lilly Business Overview
10.2.5 Eli Lilly SWOT Analysis
10.2.6 Eli Lilly Recent Developments
10.3 Sanofi
10.3.1 Sanofi Basic Information
10.3.2 Sanofi GLP-1 Therapy Product Overview
10.3.3 Sanofi GLP-1 Therapy Product Market Performance
10.3.4 Sanofi Business Overview
10.3.5 Sanofi SWOT Analysis
10.3.6 Sanofi Recent Developments
10.4 AstraZeneca (historical)
10.4.1 AstraZeneca (historical) Basic Information
10.4.2 AstraZeneca (historical) GLP-1 Therapy Product Overview
10.4.3 AstraZeneca (historical) GLP-1 Therapy Product Market Performance
10.4.4 AstraZeneca (historical) Business Overview
10.4.5 AstraZeneca (historical) Recent Developments
10.5 Teva
10.5.1 Teva Basic Information
10.5.2 Teva GLP-1 Therapy Product Overview
10.5.3 Teva GLP-1 Therapy Product Market Performance
10.5.4 Teva Business Overview
10.5.5 Teva Recent Developments
10.6 Zealand Pharma
10.6.1 Zealand Pharma Basic Information
10.6.2 Zealand Pharma GLP-1 Therapy Product Overview
10.6.3 Zealand Pharma GLP-1 Therapy Product Market Performance
10.6.4 Zealand Pharma Business Overview
10.6.5 Zealand Pharma Recent Developments
10.7 Pfizer
10.7.1 Pfizer Basic Information
10.7.2 Pfizer GLP-1 Therapy Product Overview
10.7.3 Pfizer GLP-1 Therapy Product Market Performance
10.7.4 Pfizer Business Overview
10.7.5 Pfizer Recent Developments
10.8 Merck (MSD)
10.8.1 Merck (MSD) Basic Information
10.8.2 Merck (MSD) GLP-1 Therapy Product Overview
10.8.3 Merck (MSD) GLP-1 Therapy Product Market Performance
10.8.4 Merck (MSD) Business Overview
10.8.5 Merck (MSD) Recent Developments
11 GLP-1 THERAPY MARKET FORECAST BY REGION
11.1 Global GLP-1 Therapy Market Size Forecast
11.2 Global GLP-1 Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe GLP-1 Therapy Market Size Forecast by Country
11.2.3 Asia Pacific GLP-1 Therapy Market Size Forecast by Region
11.2.4 South America GLP-1 Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of GLP-1 Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global GLP-1 Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of GLP-1 Therapy by Type (2026-2035)
12.1.2 Global GLP-1 Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of GLP-1 Therapy by Type (2026-2035)
12.2 Global GLP-1 Therapy Market Forecast by Application (2026-2035)
12.2.1 Global GLP-1 Therapy Sales (K MT) Forecast by Application
12.2.2 Global GLP-1 Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of GLP-1 Therapy
1.2 Key Market Segments
1.2.1 GLP-1 Therapy Segment by Type
1.2.2 GLP-1 Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLP-1 THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global GLP-1 Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global GLP-1 Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLP-1 THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global GLP-1 Therapy Product Life Cycle
3.3 Global GLP-1 Therapy Sales by Manufacturers (2020-2025)
3.4 Global GLP-1 Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 GLP-1 Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global GLP-1 Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 GLP-1 Therapy Market Competitive Situation and Trends
3.8.1 GLP-1 Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest GLP-1 Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GLP-1 THERAPY INDUSTRY CHAIN ANALYSIS
4.1 GLP-1 Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GLP-1 THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global GLP-1 Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to GLP-1 Therapy Market
5.7 ESG Ratings of Leading Companies
6 GLP-1 THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global GLP-1 Therapy Sales Market Share by Type (2020-2025)
6.3 Global GLP-1 Therapy Market Size by Type (2020-2025)
6.4 Global GLP-1 Therapy Price by Type (2020-2025)
7 GLP-1 THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global GLP-1 Therapy Market Sales by Application (2020-2025)
7.3 Global GLP-1 Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global GLP-1 Therapy Sales Growth Rate by Application (2020-2025)
8 GLP-1 THERAPY MARKET SALES BY REGION
8.1 Global GLP-1 Therapy Sales by Region
8.1.1 Global GLP-1 Therapy Sales by Region
8.1.2 Global GLP-1 Therapy Sales Market Share by Region
8.2 Global GLP-1 Therapy Market Size by Region
8.2.1 Global GLP-1 Therapy Market Size by Region
8.2.2 Global GLP-1 Therapy Market Size by Region
8.3 North America
8.3.1 North America GLP-1 Therapy Sales by Country
8.3.2 North America GLP-1 Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe GLP-1 Therapy Sales by Country
8.4.2 Europe GLP-1 Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific GLP-1 Therapy Sales by Region
8.5.2 Asia Pacific GLP-1 Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America GLP-1 Therapy Sales by Country
8.6.2 South America GLP-1 Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa GLP-1 Therapy Sales by Region
8.7.2 Middle East and Africa GLP-1 Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GLP-1 THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of GLP-1 Therapy by Region(2020-2025)
9.2 Global GLP-1 Therapy Revenue Market Share by Region (2020-2025)
9.3 Global GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America GLP-1 Therapy Production
9.4.1 North America GLP-1 Therapy Production Growth Rate (2020-2025)
9.4.2 North America GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe GLP-1 Therapy Production
9.5.1 Europe GLP-1 Therapy Production Growth Rate (2020-2025)
9.5.2 Europe GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan GLP-1 Therapy Production (2020-2025)
9.6.1 Japan GLP-1 Therapy Production Growth Rate (2020-2025)
9.6.2 Japan GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China GLP-1 Therapy Production (2020-2025)
9.7.1 China GLP-1 Therapy Production Growth Rate (2020-2025)
9.7.2 China GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novo Nordisk
10.1.1 Novo Nordisk Basic Information
10.1.2 Novo Nordisk GLP-1 Therapy Product Overview
10.1.3 Novo Nordisk GLP-1 Therapy Product Market Performance
10.1.4 Novo Nordisk Business Overview
10.1.5 Novo Nordisk SWOT Analysis
10.1.6 Novo Nordisk Recent Developments
10.2 Eli Lilly
10.2.1 Eli Lilly Basic Information
10.2.2 Eli Lilly GLP-1 Therapy Product Overview
10.2.3 Eli Lilly GLP-1 Therapy Product Market Performance
10.2.4 Eli Lilly Business Overview
10.2.5 Eli Lilly SWOT Analysis
10.2.6 Eli Lilly Recent Developments
10.3 Sanofi
10.3.1 Sanofi Basic Information
10.3.2 Sanofi GLP-1 Therapy Product Overview
10.3.3 Sanofi GLP-1 Therapy Product Market Performance
10.3.4 Sanofi Business Overview
10.3.5 Sanofi SWOT Analysis
10.3.6 Sanofi Recent Developments
10.4 AstraZeneca (historical)
10.4.1 AstraZeneca (historical) Basic Information
10.4.2 AstraZeneca (historical) GLP-1 Therapy Product Overview
10.4.3 AstraZeneca (historical) GLP-1 Therapy Product Market Performance
10.4.4 AstraZeneca (historical) Business Overview
10.4.5 AstraZeneca (historical) Recent Developments
10.5 Teva
10.5.1 Teva Basic Information
10.5.2 Teva GLP-1 Therapy Product Overview
10.5.3 Teva GLP-1 Therapy Product Market Performance
10.5.4 Teva Business Overview
10.5.5 Teva Recent Developments
10.6 Zealand Pharma
10.6.1 Zealand Pharma Basic Information
10.6.2 Zealand Pharma GLP-1 Therapy Product Overview
10.6.3 Zealand Pharma GLP-1 Therapy Product Market Performance
10.6.4 Zealand Pharma Business Overview
10.6.5 Zealand Pharma Recent Developments
10.7 Pfizer
10.7.1 Pfizer Basic Information
10.7.2 Pfizer GLP-1 Therapy Product Overview
10.7.3 Pfizer GLP-1 Therapy Product Market Performance
10.7.4 Pfizer Business Overview
10.7.5 Pfizer Recent Developments
10.8 Merck (MSD)
10.8.1 Merck (MSD) Basic Information
10.8.2 Merck (MSD) GLP-1 Therapy Product Overview
10.8.3 Merck (MSD) GLP-1 Therapy Product Market Performance
10.8.4 Merck (MSD) Business Overview
10.8.5 Merck (MSD) Recent Developments
11 GLP-1 THERAPY MARKET FORECAST BY REGION
11.1 Global GLP-1 Therapy Market Size Forecast
11.2 Global GLP-1 Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe GLP-1 Therapy Market Size Forecast by Country
11.2.3 Asia Pacific GLP-1 Therapy Market Size Forecast by Region
11.2.4 South America GLP-1 Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of GLP-1 Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global GLP-1 Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of GLP-1 Therapy by Type (2026-2035)
12.1.2 Global GLP-1 Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of GLP-1 Therapy by Type (2026-2035)
12.2 Global GLP-1 Therapy Market Forecast by Application (2026-2035)
12.2.1 Global GLP-1 Therapy Sales (K MT) Forecast by Application
12.2.2 Global GLP-1 Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global GLP-1 Therapy Market Size by Type (M USD)
Table 4. Global GLP-1 Therapy Market Size by Application
Table 5. GLP-1 Therapy Market Size Comparison by Region (M USD)
Table 6. Global GLP-1 Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global GLP-1 Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global GLP-1 Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global GLP-1 Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1 Therapy as of 2025)
Table 11. Global Market GLP-1 Therapy Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global GLP-1 Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. GLP-1 Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global GLP-1 Therapy Sales by Type (K MT)
Table 27. Global GLP-1 Therapy Market Size by Type (M USD)
Table 28. Global GLP-1 Therapy Sales (K MT) by Type (2020-2025)
Table 29. Global GLP-1 Therapy Sales Market Share by Type (2020-2025)
Table 30. Global GLP-1 Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global GLP-1 Therapy Market Share by Type (2020-2025)
Table 32. Global GLP-1 Therapy Price (USD/KG) by Type (2020-2025)
Table 33. Global GLP-1 Therapy Sales (K MT) by Application
Table 34. Global GLP-1 Therapy Market Size by Application
Table 35. Global GLP-1 Therapy Sales by Application (2020-2025) & (K MT)
Table 36. Global GLP-1 Therapy Sales Market Share by Application (2020-2025)
Table 37. Global GLP-1 Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global GLP-1 Therapy Market Share by Application (2020-2025)
Table 39. Global GLP-1 Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global GLP-1 Therapy Sales by Region (2020-2025) & (K MT)
Table 41. Global GLP-1 Therapy Sales Market Share by Region (2020-2025)
Table 42. Global GLP-1 Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global GLP-1 Therapy Market Size by Region (2020-2025)
Table 44. North America GLP-1 Therapy Sales by Country (2020-2025) & (K MT)
Table 45. North America GLP-1 Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe GLP-1 Therapy Sales by Country (2020-2025) & (K MT)
Table 47. Europe GLP-1 Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific GLP-1 Therapy Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific GLP-1 Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America GLP-1 Therapy Sales by Country (2020-2025) & (K MT)
Table 51. South America GLP-1 Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa GLP-1 Therapy Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa GLP-1 Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global GLP-1 Therapy Production (K MT) by Region(2020-2025)
Table 55. Global GLP-1 Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global GLP-1 Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novo Nordisk Basic Information
Table 63. Novo Nordisk GLP-1 Therapy Product Overview
Table 64. Novo Nordisk GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novo Nordisk Business Overview
Table 66. Novo Nordisk SWOT Analysis
Table 67. Novo Nordisk Recent Developments
Table 68. Eli Lilly Basic Information
Table 69. Eli Lilly GLP-1 Therapy Product Overview
Table 70. Eli Lilly GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Eli Lilly Business Overview
Table 72. Eli Lilly SWOT Analysis
Table 73. Eli Lilly Recent Developments
Table 74. Sanofi Basic Information
Table 75. Sanofi GLP-1 Therapy Product Overview
Table 76. Sanofi GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Sanofi Business Overview
Table 78. Sanofi SWOT Analysis
Table 79. Sanofi Recent Developments
Table 80. AstraZeneca (historical) Basic Information
Table 81. AstraZeneca (historical) GLP-1 Therapy Product Overview
Table 82. AstraZeneca (historical) GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. AstraZeneca (historical) Business Overview
Table 84. AstraZeneca (historical) Recent Developments
Table 85. Teva Basic Information
Table 86. Teva GLP-1 Therapy Product Overview
Table 87. Teva GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Teva Business Overview
Table 89. Teva Recent Developments
Table 90. Zealand Pharma Basic Information
Table 91. Zealand Pharma GLP-1 Therapy Product Overview
Table 92. Zealand Pharma GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Zealand Pharma Business Overview
Table 94. Zealand Pharma Recent Developments
Table 95. Pfizer Basic Information
Table 96. Pfizer GLP-1 Therapy Product Overview
Table 97. Pfizer GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Pfizer Business Overview
Table 99. Pfizer Recent Developments
Table 100. Merck (MSD) Basic Information
Table 101. Merck (MSD) GLP-1 Therapy Product Overview
Table 102. Merck (MSD) GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Merck (MSD) Business Overview
Table 104. Merck (MSD) Recent Developments
Table 105. Global GLP-1 Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global GLP-1 Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America GLP-1 Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America GLP-1 Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe GLP-1 Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe GLP-1 Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific GLP-1 Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific GLP-1 Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America GLP-1 Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America GLP-1 Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa GLP-1 Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa GLP-1 Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global GLP-1 Therapy Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global GLP-1 Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global GLP-1 Therapy Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global GLP-1 Therapy Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global GLP-1 Therapy Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global GLP-1 Therapy Market Size by Type (M USD)
Table 4. Global GLP-1 Therapy Market Size by Application
Table 5. GLP-1 Therapy Market Size Comparison by Region (M USD)
Table 6. Global GLP-1 Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global GLP-1 Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global GLP-1 Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global GLP-1 Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1 Therapy as of 2025)
Table 11. Global Market GLP-1 Therapy Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global GLP-1 Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. GLP-1 Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global GLP-1 Therapy Sales by Type (K MT)
Table 27. Global GLP-1 Therapy Market Size by Type (M USD)
Table 28. Global GLP-1 Therapy Sales (K MT) by Type (2020-2025)
Table 29. Global GLP-1 Therapy Sales Market Share by Type (2020-2025)
Table 30. Global GLP-1 Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global GLP-1 Therapy Market Share by Type (2020-2025)
Table 32. Global GLP-1 Therapy Price (USD/KG) by Type (2020-2025)
Table 33. Global GLP-1 Therapy Sales (K MT) by Application
Table 34. Global GLP-1 Therapy Market Size by Application
Table 35. Global GLP-1 Therapy Sales by Application (2020-2025) & (K MT)
Table 36. Global GLP-1 Therapy Sales Market Share by Application (2020-2025)
Table 37. Global GLP-1 Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global GLP-1 Therapy Market Share by Application (2020-2025)
Table 39. Global GLP-1 Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global GLP-1 Therapy Sales by Region (2020-2025) & (K MT)
Table 41. Global GLP-1 Therapy Sales Market Share by Region (2020-2025)
Table 42. Global GLP-1 Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global GLP-1 Therapy Market Size by Region (2020-2025)
Table 44. North America GLP-1 Therapy Sales by Country (2020-2025) & (K MT)
Table 45. North America GLP-1 Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe GLP-1 Therapy Sales by Country (2020-2025) & (K MT)
Table 47. Europe GLP-1 Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific GLP-1 Therapy Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific GLP-1 Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America GLP-1 Therapy Sales by Country (2020-2025) & (K MT)
Table 51. South America GLP-1 Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa GLP-1 Therapy Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa GLP-1 Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global GLP-1 Therapy Production (K MT) by Region(2020-2025)
Table 55. Global GLP-1 Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global GLP-1 Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novo Nordisk Basic Information
Table 63. Novo Nordisk GLP-1 Therapy Product Overview
Table 64. Novo Nordisk GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novo Nordisk Business Overview
Table 66. Novo Nordisk SWOT Analysis
Table 67. Novo Nordisk Recent Developments
Table 68. Eli Lilly Basic Information
Table 69. Eli Lilly GLP-1 Therapy Product Overview
Table 70. Eli Lilly GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Eli Lilly Business Overview
Table 72. Eli Lilly SWOT Analysis
Table 73. Eli Lilly Recent Developments
Table 74. Sanofi Basic Information
Table 75. Sanofi GLP-1 Therapy Product Overview
Table 76. Sanofi GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Sanofi Business Overview
Table 78. Sanofi SWOT Analysis
Table 79. Sanofi Recent Developments
Table 80. AstraZeneca (historical) Basic Information
Table 81. AstraZeneca (historical) GLP-1 Therapy Product Overview
Table 82. AstraZeneca (historical) GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. AstraZeneca (historical) Business Overview
Table 84. AstraZeneca (historical) Recent Developments
Table 85. Teva Basic Information
Table 86. Teva GLP-1 Therapy Product Overview
Table 87. Teva GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Teva Business Overview
Table 89. Teva Recent Developments
Table 90. Zealand Pharma Basic Information
Table 91. Zealand Pharma GLP-1 Therapy Product Overview
Table 92. Zealand Pharma GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Zealand Pharma Business Overview
Table 94. Zealand Pharma Recent Developments
Table 95. Pfizer Basic Information
Table 96. Pfizer GLP-1 Therapy Product Overview
Table 97. Pfizer GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Pfizer Business Overview
Table 99. Pfizer Recent Developments
Table 100. Merck (MSD) Basic Information
Table 101. Merck (MSD) GLP-1 Therapy Product Overview
Table 102. Merck (MSD) GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Merck (MSD) Business Overview
Table 104. Merck (MSD) Recent Developments
Table 105. Global GLP-1 Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global GLP-1 Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America GLP-1 Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America GLP-1 Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe GLP-1 Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe GLP-1 Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific GLP-1 Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific GLP-1 Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America GLP-1 Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America GLP-1 Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa GLP-1 Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa GLP-1 Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global GLP-1 Therapy Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global GLP-1 Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global GLP-1 Therapy Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global GLP-1 Therapy Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global GLP-1 Therapy Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of GLP-1 Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global GLP-1 Therapy Market Size (M USD), 2025-2035
Figure 5. Global GLP-1 Therapy Market Size (M USD) (2020-2035)
Figure 6. Global GLP-1 Therapy Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. GLP-1 Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global GLP-1 Therapy Product Life Cycle
Figure 13. GLP-1 Therapy Sales Share by Manufacturers in 2025
Figure 14. Global GLP-1 Therapy Revenue Share by Manufacturers in 2025
Figure 15. GLP-1 Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market GLP-1 Therapy Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by GLP-1 Therapy Revenue in 2025
Figure 18. Industry Chain Map of GLP-1 Therapy
Figure 19. Global GLP-1 Therapy Market PEST Analysis
Figure 20. Global GLP-1 Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global GLP-1 Therapy Market Share by Type
Figure 27. Sales Market Share of GLP-1 Therapy by Type (2020-2025)
Figure 28. Sales Market Share of GLP-1 Therapy by Type in 2025
Figure 29. Market Share of GLP-1 Therapy by Type (2020-2025)
Figure 30. Market Share of GLP-1 Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global GLP-1 Therapy Market Share by Application
Figure 33. Global GLP-1 Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global GLP-1 Therapy Sales Market Share by Application in 2025
Figure 35. Global GLP-1 Therapy Market Share by Application (2020-2025)
Figure 36. Global GLP-1 Therapy Market Share by Application in 2025
Figure 37. Global GLP-1 Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global GLP-1 Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global GLP-1 Therapy Market Size by Region (2020-2025)
Figure 40. North America GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America GLP-1 Therapy Sales Market Share by Country in 2024
Figure 43. North America GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America GLP-1 Therapy Market Size by Country in 2024
Figure 45. U.S. GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada GLP-1 Therapy Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada GLP-1 Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico GLP-1 Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico GLP-1 Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe GLP-1 Therapy Sales Market Share by Country in 2024
Figure 53. Europe GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe GLP-1 Therapy Market Size by Country in 2024
Figure 55. Germany GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific GLP-1 Therapy Sales and Growth Rate (K MT)
Figure 66. Asia Pacific GLP-1 Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific GLP-1 Therapy Market Size by Region in 2024
Figure 68. China GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America GLP-1 Therapy Sales and Growth Rate (K MT)
Figure 79. South America GLP-1 Therapy Sales Market Share by Country in 2024
Figure 80. South America GLP-1 Therapy Market Size and Growth Rate (M USD)
Figure 81. South America GLP-1 Therapy Market Size by Country in 2024
Figure 82. Brazil GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa GLP-1 Therapy Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa GLP-1 Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa GLP-1 Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa GLP-1 Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global GLP-1 Therapy Production Market Share by Region (2020-2025)
Figure 103. North America GLP-1 Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe GLP-1 Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan GLP-1 Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. China GLP-1 Therapy Production (K MT) Growth Rate (2020-2025)
Figure 107. Global GLP-1 Therapy Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global GLP-1 Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global GLP-1 Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global GLP-1 Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global GLP-1 Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global GLP-1 Therapy Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of GLP-1 Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global GLP-1 Therapy Market Size (M USD), 2025-2035
Figure 5. Global GLP-1 Therapy Market Size (M USD) (2020-2035)
Figure 6. Global GLP-1 Therapy Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. GLP-1 Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global GLP-1 Therapy Product Life Cycle
Figure 13. GLP-1 Therapy Sales Share by Manufacturers in 2025
Figure 14. Global GLP-1 Therapy Revenue Share by Manufacturers in 2025
Figure 15. GLP-1 Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market GLP-1 Therapy Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by GLP-1 Therapy Revenue in 2025
Figure 18. Industry Chain Map of GLP-1 Therapy
Figure 19. Global GLP-1 Therapy Market PEST Analysis
Figure 20. Global GLP-1 Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global GLP-1 Therapy Market Share by Type
Figure 27. Sales Market Share of GLP-1 Therapy by Type (2020-2025)
Figure 28. Sales Market Share of GLP-1 Therapy by Type in 2025
Figure 29. Market Share of GLP-1 Therapy by Type (2020-2025)
Figure 30. Market Share of GLP-1 Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global GLP-1 Therapy Market Share by Application
Figure 33. Global GLP-1 Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global GLP-1 Therapy Sales Market Share by Application in 2025
Figure 35. Global GLP-1 Therapy Market Share by Application (2020-2025)
Figure 36. Global GLP-1 Therapy Market Share by Application in 2025
Figure 37. Global GLP-1 Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global GLP-1 Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global GLP-1 Therapy Market Size by Region (2020-2025)
Figure 40. North America GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America GLP-1 Therapy Sales Market Share by Country in 2024
Figure 43. North America GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America GLP-1 Therapy Market Size by Country in 2024
Figure 45. U.S. GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada GLP-1 Therapy Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada GLP-1 Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico GLP-1 Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico GLP-1 Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe GLP-1 Therapy Sales Market Share by Country in 2024
Figure 53. Europe GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe GLP-1 Therapy Market Size by Country in 2024
Figure 55. Germany GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific GLP-1 Therapy Sales and Growth Rate (K MT)
Figure 66. Asia Pacific GLP-1 Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific GLP-1 Therapy Market Size by Region in 2024
Figure 68. China GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America GLP-1 Therapy Sales and Growth Rate (K MT)
Figure 79. South America GLP-1 Therapy Sales Market Share by Country in 2024
Figure 80. South America GLP-1 Therapy Market Size and Growth Rate (M USD)
Figure 81. South America GLP-1 Therapy Market Size by Country in 2024
Figure 82. Brazil GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa GLP-1 Therapy Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa GLP-1 Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa GLP-1 Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa GLP-1 Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global GLP-1 Therapy Production Market Share by Region (2020-2025)
Figure 103. North America GLP-1 Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe GLP-1 Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan GLP-1 Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. China GLP-1 Therapy Production (K MT) Growth Rate (2020-2025)
Figure 107. Global GLP-1 Therapy Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global GLP-1 Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global GLP-1 Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global GLP-1 Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global GLP-1 Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global GLP-1 Therapy Market Share Forecast by Application (2026-2035)
